Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells
Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells have?
Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells has 356 citations in the OpenAlex counts ScholarIQ stores.
When was Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells published?
Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells has 2019 year in the ScholarIQ index.
What is the open-access status of Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells?
Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells has hybrid oa status in the ScholarIQ index.
What is the DOI of Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells?
The DOI for Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells is on the source record.
What is the PMID of Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells?
The PMID for Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells is on the source record.
What is the OpenAlex record for Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells?
The OpenAlex for Late Events after Treatment with CD19-Targeted Chimeric Antigen Receptor Modified T Cells is on the source record.